PR91260

Excelra launches a re-envisioned version of GOSTAR, its structure-activity relationship application, with an innovative set of new features to accelerate the drug discovery cycle

HYDERABAD, India, Aug. 23 /PRNewswire=KYODO JBN/ --

    Today, Excelra [https://www.excelra.com/], a global data science and data

analytics company, unveiled an improved version of GOSTAR

[https://www.gostardb.com/], its flagship chemistry insights engine. The

enhancements offer advanced search, analysis, and visualization capabilities

enabling drug discovery scientists to accelerate the hit identification and

lead optimization process.

    "Drug discovery researchers need to ensure that they are getting the

broadest possible view of structure-activity data while being able to readily

drill down to the most meaningful data points. The new GOSTAR version has been

re-envisioned based on extensive user feedback to provide researchers with an

intuitive interface that reduces time to market for new drugs. It incorporates

analytical capabilities, eliminating the need to use multiple tools to assess

compounds while also providing insights directly within the application. The

result is a rapid and more confident decision-making process," said Norman

Azoulay, Director, Scientific Products.

    GOSTAR's industry-leading capabilities include:

    - Advanced Search: Discover insights faster with dynamic, flexible, and

interactive search capabilities

    - SAR View: View, sort, and export structures based on activity against

targets of interest

    - Analytics: Compare compounds and perform Molecular pair, maximum common

substructure, and ligand efficiency vs. ligand-lipophilicity efficiency analyses

    All data in GOSTAR, which now includes over 8 million compounds, along with

bioactivity data, is subjected to a three-tiered, QMS-ISO certified quality

control process. The standardization and normalization of all data provide

additional clarity while ensuring it is directly and readily comparable.

    "Excelra aims to transform life science data into actionable insights for

our R&D clients that help them to innovate and accelerate their drug discovery.

The enhancements made to GOSTAR will improve the ability to make meaningful

predictions and lead to more promising pipelines," said Anandbir Singh Brar,

CEO, Excelra.

    GOSTAR is available as an application for users to seek, find, and discover

compounds. In addition, it is offered via APIs and as a downloadable dataset to

power in-house libraries and machine learning models.

    For more information about GOSTAR, visit www.gostardb.com

    About Excelra

    Excelra's data and analytics solutions empower innovation in life sciences

from molecule to market. The Excelra Edge comes from a seamless amalgamation of

proprietary data assets, domain expertise and, data science to accelerate drug

discovery and development. For more information, visit www.excelra.com.

    For media inquiries, contact:

    Jigesh Shah

    Jigesh.shah@excelra.com

    +91-9820444994

    Logo: https://mma.prnewswire.com/media/1599641/GOSTAR_Logo.jpg

    Source: Excelra Knowledge Solutions Pvt Ltd